Franz Humer Joines the Board of BIAL
BIAL, the largest Portuguese pharmaceutical company and one of the major Iberian, has just incorporated as a non-executive Board member, Franz Humer, former CEO and Chairman of Roche.
The incorporation of Franz Humer, one of the most internationally respected personalities in the pharmaceutical industry, is part of the consolidation of BIAL’s internationalization strategy for the next decade.
Franz Humer, who retired from Roche in 2014, has a long career in the pharmaceutical industry, having previously held management positions at Schering Plough and GlaxoSmithKline. In 1995 he joined the Board of Roche, as head of the Pharmaceutical Division and as Chief Operating Officer. From 1998 until 2008, he took over as CEO and, from 2001 until March 2014, as Chairman.
Graduated with a PhD in Law, an MBA from INSEAD, Franz Humer is a member of the Board of Citigroup, Chairman of Diageo, Chairman of the International Center for Missing and Exploited Children and Member of the International Advisory Board of Allianz, among other positions.
Luís Portela, Chairman of BIAL, said: "It is an honor to count on the experience of Dr Franz Humer, who dedicated his professional career to the pharmaceutical industry in large multinational companies of innovation. His incorporation is especially relevant to BIAL as it is a recognition of the work we have been developing."
According to Franz Humer "to be part of BIAL's Board is a challenge. I’ve been following BIAL for many years and I think it has made a remarkable journey, based on a long-term strategy focused on R&D, which is a pioneer work in Portugal. I’m really excited to give my contribution to its strengthening, particularly in the international markets."
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance